Finance

Lists
Why is PCJ down 3,45%?
Dive Deeper
PCJ:FRA
Abeona Therapeutics Inc
3,81 €
-3,45%
(-0,14) 1D
15 қаз., 08:00:49 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PCJ...
Open
3,81 €
High
3,81 €
Low
3,81 €
Mkt. cap
249,32 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
7,08 €
52-wk low
3,56 €
No. of employees
226
Open
3,81 €
High
3,81 €
Low
3,81 €
Mkt. cap
249,32 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
7,08 €
52-wk low
3,56 €
No. of employees
226
News stories
From web sources and news partners
About Abeona Therapeutics Inc
CEO-
Employees226
Founded1974
HeadquartersКливленд, Огайо, Америка Құрама Штаттары
Sector-
Websiteabeonatherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
5,42 млн
8,72 млн
11,38 млн
Cost of goods sold
4,70 млн
9,55 млн
12,25 млн
9,20 млн
Cost of revenue
4,70 млн
9,55 млн
12,25 млн
9,20 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,31 млн
18,78 млн
19,50 млн
15,84 млн
Operating expense
19,31 млн
18,78 млн
19,50 млн
15,84 млн
Total operating expenses
24,02 млн
28,33 млн
31,75 млн
25,03 млн
Operating income
-24,02 млн
-22,91 млн
-23,03 млн
-13,65 млн
Other non operating income
2,89 млн
1,57 млн
5,44 млн
-7,20 млн
EBT including unusual items
-20,36 млн
-20,68 млн
-17,07 млн
-20,19 млн
EBT excluding unusual items
-20,36 млн
-20,68 млн
-17,07 млн
-20,19 млн
Income tax expense
-15,20 млн
-215,00 м.
2,00 мың
-
Effective tax rate
74,65%
1,04%
-0,01%
-
Other operating expenses
-
-
-
-
Net income
-5,16 млн
-20,46 млн
-17,08 млн
-20,19 млн
Net profit margin
-
-377,49%
-195,81%
-177,43%
Earnings per share
-0,11
-0,37
-0,30
-0,35
Interest and investment income
1,67 млн
1,55 млн
1,35 млн
1,36 млн
Interest expense
-901,00 м.
-884,00 м.
-830,00 м.
-696,00 м.
Net interest expenses
771,00 м.
663,00 м.
524,00 м.
659,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-23,41 млн
-22,05 млн
-22,34 млн
-12,99 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары